BioTrinity 2011 participants
BioTrinity 2012 participants will be available here shortly. See below who attended in 2011.
BioTrinity 2011 bought together investors, global phama and innovative biotech and medtech R&D companies under one roof. With more than 75 investment firms attending in 2011 amongst 750 delegates from 450 participant companies from 20 countries onboard, making BioTrinity once again the largest gathering of the UK bioindustry. Investment firms constituted nearly one fifth of the conference participants (76 firms), and corporate venturers and senior licensing / business development execs from Novartis, AstraZeneca, Roche, Shire, Merck, GSK, Sanofi Aventis, Pfizer, Boehringer, Baxter, Takeda, Teva, Lilly, Smith & Nephew, Fosun Pharma, Ironwood, Merck Serono, Abbott, Novo A/S, J&J and Lundbeckfund also attended in 2011 maintaining BioTrinity again as an ever-expanding well organized and unique offering of valuable investor and pharma partnering opportunities.
Read the testimonials received from delegates from previous years to find out what other delegates say...
See who attended in 2011:
- Abbott Biotech Ventures (US)
- AbD Serotec
- Abgent Europe
- Abingworth LLP
- AB-Therapeutics (Spain)
- ACM Global Central Laboratory
- Adaptimmune
- Advent Venture Partners
- Aelios Finance (France)
- Aescap Venture (Netherlands)
- Affimed Therapeutics AG (Germany)
- Ajinomoto co., Inc. (Japan)
- Alacrita
- Albion Ventures
- Alchemy Healthcare
- Allergan
- Almac
- Alzprotect (France)
- Amadeus Capital Partners
- Amakem NV (Belgium)
- Ambicare Health
- A. Menarini IFR (Italy)
- AMRI
- Apex Healthcare Consulting
- Apitope
- Apposite Capital
- APTBio Ltd
- Aptuit, Inc. (US)
- Aquapharma Discovery
- Aquarius Equity Partners
- Arcamis Limited
- Arrayjet
- Astex Therapeutics Limited
- Aston University
- AstraZeneca
- APTBio Ltd
- Atlas Venture (United States)
- AvantiCell Science
- Babraham Bioscience Technologies
- Babraham Institute
- BASi
- Baxter Healthcare
- Begbroke Science Park
- Bench International
- BIA
- Bicycle Therapeutics
- BigBear Communications
- Bilcare GCS Europe Ltd
- Bioalternatives (France)
- BioCity Nottingham
- BioDundee
- BioEdge Pharma Consultancy Ltd
- BioFocus
- Bioneer A/S (Denmark)
- BioPark/BABS Biomarker Services
- Biopharma Process Systems
- Biopharm Insight (media)
- BioProcess Technology Consultants, Inc. (USA)
- Biopta
- BioScience Managers Limited
- Biotech Personnel
- BiotechSubsidy (Belgium)
- Biotec Services International
- Biotrial International
- BioVex
- BioWin (Belgium)
- BiOxyDyn
- Black Swan Analysis
- Boehringer Ingelheim Venture Fund (Germany)
- Boult Wade Tennant
- Bridgehead International
- BSG TV
- Cambridge Enterprise Ltd
- Cambridge Research Biochemicals
- Cancer Research Technology Ltd
- Catalent Pharma Solutions (France)
- CDSS
- CellAura Technologies Ltd
- CellCentric
- Cellecta Inc. (USA)
- Cell Medica
- Cellvax (France)
- Cellzome
- Cels NEPAF
- Celtic Pharma Holdings Advisors LLP
- CEM Analytical Services
- Citeline Drug Intelligence
- Charles River BPS (Germany)
- Charles Russell LLP
- Chemistry World (Media)
- Chempetitive
- Chroma Therapeutics
- Cinetique Translations
- Citeline Drug Intelligence (Press)
- Citigate Dewe Rogersen
- Clinica (media)
- Clinical Development and Support Services Ltd (CDSS)
- Clinical Network Services (CNS) Pty Ltd (Australia)
- Clubb Capital Ltd
- CMP Therapeutics
- CMS Cameron McKenna LLP
- College Hill Life Sciences
- Collins Stewart Europe
- Coller IP Management Ltd
- Colloidal Resource (Sweden)
- Colworth Science Park
- Commitum (Sweden)
- Complix
- The Communications Strategy Group Inc. (US)
- Competitive Drug Development International
- Conformetrix
- Consultant - Warwick Bryant (Australia)
- CR Competence
- Covance Laboratories
- CR Development
- Credit Agricole Private Equity (France)
- Crescendo Biologics
- Critical Pharmaceuticals
- CTPartners
- C-TRIC
- Cyprotex Discovery plc
- Cytox
- CXR BioSciences Ltd
- CXR Discovery
- Datum Developments
- Debiopharm SA (Switzerland)
- Defined Health (Switzerland)
- Dehns
- Delta Partners (Ireland)
- DestiNA Genomics
- DFJ Esprit LLP
- Diligent Consulting
- Dishman Group
- Domainex
- DSM Venturing (Netherlands)
- Drug Discovery Today (Media)
- Eagle Genomics
- EBD Group
- ECI Partners
- Edwards Angell Palmer & Dodge
- Edinburgh Bioquarter
- Edison Investment Research
- Edmond de Rothchild Investment Partners (France)
- EKF Diagnostics (Germany)
- Eli Lilly
- Elsevier (Press)
- Entrepreneurs Fund
- EpiStem ltd
- ERA Consulting UK
- ERGOMED Group
- Essen Bioscience
- e-Therapeutics plc
- ETV Capital
- Euprotec Ltd
- Eurobiomed (France)
- Eurobiomed-Euromediag (France)
- Eurogentec Biologics (Belgium)
- EUSA Pharma
- Evolution Securities
- Evotec (UK) Ltd
- Excalibur
- Fasken Martineau LLP
- Field Fisher Waterhouse
- Finance Wales
- Fisher Scientific
- FOCUS Insurance
- Forresters
- Forbion Capital Partners (Netherlands)
- Forresters
- Fosun Pharma (China)
- Fountain Healthcare Partners
- Fry Heath Spence
- Future Injection Technologies
- Galenica (Sweden)
- GeneFirst
- Genetrix SL (Spain)
- Gen-probe Life Sciences
- Gentronix
- george james
- Gerson Lehrman Group
- GFA
- Glysure
- Grove Lodge Consulting
- GSK (CEEDD)
- GxPi
- Halo BioConsulting Ltd
- Harlan Laboratories
- Harrison Clinical Research
- Harwell Science Park
- Hays Pharma
- H20 Venture Partners
- Health Protection Agency
- HealthTIES
- Heptares Therapeutics Ltd
- High Force Research Ltd
- HLS
- HMA Digital Marketing
- Horton Ruston Poole
- Horus Security Consultancy
- ICDD (France)
- ICON Development Solutions
- Illetrop Ltd
- Immunocore
- Imperial Innovations (Investment side)
- INC Research
- Innaxon
- Innova Biosciences Ltd
- Innovacell Biotechnologie AG (Austria)
- Innovaro Europe
- Institut Català d'investigació Química
- Integrated Magnetic Systems
- Intelligent Pharma (Spain)
- Interea International
- International Bioscience Managers
- International Labmate (Media)
- Intertek Pharmaceutical Services
- Inventages
- Inventages Venture Capital
- Invest in Skane (Sweden)
- In Vivo (media)
- Ion Channel Biotechnology Centre
- IP Asset Ventures
- IP Group plc
- IPSO Ventures
- IPT Pharma
- IPT Magazine (Press)
- IQ Capital Partners LLP
- Ironwood Pharmaceuticals (US)
- Isis Innovation
- Isogenica
- JA Kemp & Co
- James Cowper
- John Innes Centre
- Jonathan Kwok
- JPT Peptide Technology GmbH (Germany)
- Kancera AB (Sweden)
- Kelly Scientific Resources
- King's College London
- KPMG
- KWS Biotest
- Lab Support
- Lacerta Bio BD&L
- Lacerta Bio Inc. (US)
- LD Invest Life Science Capital (Denmark)
- Leiden Bioscience Park Foundation (Netherlands)
- Liverpool Life Sciences
- Liverpool Science Park
- London Economic Development Corporation (Canada)
- LRM (Belgium)
- Lumemed
- Lundbeckfond Ventures
- Malvern Cosmeceutics
- Manches LLP
- Mathys & Squire LLP
- Matrix Corporate Capital
- Matrix Group Investment Banking Division
- McEwen Laboratories
- M:Communications
- Medical Delta (Netherlands)
- MedNous (Press)
- Melbourn Scientific
- MEPC Milton Park
- Mercia Fund Management
- Mergermarket (FT Group)
- Merck Serono Ventures (Switzerland)
- Mergermarket (media)
- Michelson Diagnostics
- Midven
- Mirabaud Securities
- MODE Diagnostics
- Molecular Profiles
- Morningside (China / US)
- MorphoSys AG
- MorphoSys UK Ltd T/A AbD Serotec
- Morrison & Foerster (Germany)
- MRC Harwell
- MSD
- MSD BioManufacturing Network
- MP Healthcare Venture Management, Inc. (US)
- MVM Life Science Partners LLP
- Myotec Therapeutics
- NanoSight
- nanoTherics Ltd
- Nature (media)
- Nature Biotechnology (media)
- NDA Group
- NeoMed (Switzerland)
- Neurogenix Ltd
- Neurotune (Switzerland)
- New Hill Management
- Next Control Systems - Tutela
- Nightingale Associates
- NovaBiotics Ltd
- Novartis (USA)
- Novasep (France)
- Novella Clinical
- Novexel (France)
- Novo A/S (Denmark)
- NOXXON Pharma AG (Germany)
- Numerus
- O2H
- OBN
- OCT Consulting (Russian Federation)
- OctoPlus (Netherlands)
- One Nucleus
- OrganOx
- Orthox
- ORSETEC
- Oryzon (Spain)
- Osborne Clarke
- Oval Medical Technologies Ltd
- Oxford BioMedica
- Oxford Biomedical Research Centre
- Oxford Brookes University
- Oxford Capital Partners
- Oxford Expression Technologies
- Oxford Gene Technology IP
- Oxford Nutrascience Ltd
- Oxford Science Park
- Oxford Technology Management
- Partner International Inc. (Canada)
- Patheon
- Paul Capital
- Peel Hunt
- Penn Pharma
- Pera
- Pfizer (USA)
- PGXIS
- Pharmaceutical Project Management Services
- Pharmafocus (Press)
- PharmaVentures
- PharmaWire (media)
- Pharmovation Ltd
- Phase4 Ventures
- PhotoBiotics
- Phylogica
- Physiomics plc
- Pipeline Biotech (Denmark)
- PiR Interims
- Piramal Healthcare
- Pivotal Scientific
- Plasticell Limited
- Plasticell Therapeutics
- Plethora Solutions
- Ploughshare Innovations
- PolyTherics
- Potter Clarkson LLP
- PRA International
- PregLem SA (Switzerland)
- ProCarta Biosystems
- Pro-Cure Therapeutics
- ProPharma Partners Limited
- Prosarix Ltd
- Prosidion (part of Astellas)
- Protaffin Biotechnologie (Austria)
- Protagen AG (Germany)
- Providion
- Proximagen
- PSI (Ireland)
- QED Clinical Services
- Q Chip
- QSIant
- Quality Assistance SA (Belgium)
- Quay Pharmaceuticals
- Quest Diagnostics Clinical Trials
- QuickSTAT
- Quotient Clinical Sciences
- R5 Pharmaceuticals
- Rainbow Seed Fund
- Randox Pharma Services
- Raquel Hughes
- Raumedic
- R&D Focus (Press)
- Reading Scientific Services
- RecipharmCobra Biologics
- Red Moon Executive Search
- Reed Scientific
- Regional Economic Development Inc. (US)
- Regulatory Resources Group Ltd
- Remtec Search and Selection
- Ridge & Partners LLP
- Riverbank IT Management Ltd
- Roche Pharma Partnering
- Royal Society Enterprise Fund
- RSA
- RSSL Pharma
- Rules Based Medicine, Inc. (US)
- SAFC Contract Manufacturing
- Safeguard Biosystems Holdings Ltd
- Salusion (Netherlands)
- Samedan Ltd (Press)
- SANIFIT Laboratoris (Spain)
- SANYO E&E Europe BV
- Satellite
- sanofi-aventis (France)
- Saretius
- SARomics Biostructures Ab (Sweden)
- Satellite
- Scancell Holdings plc
- Science Port Holland (Netherlands)
- Scientific Laboratory Supplies
- SCRIP (media)
- S-cubed
- Selcia
- Senectus Therapeutics
- SEP
- Sequani Limited
- Seroba Kernel Life Sciences (Ireland)
- Serotec
- Seventure Partners (France)
- Shanghai Fosun Pharmaceutical (China)
- Shire plc
- Shire-Movetis NV (Belgium)
- Shire Pharmaceuticals
- Shire Strategic Investment Group
- Siegfried
- Silence Therapeutics
- Simbec Research
- Singer Capital Markets
- SmartSensor Telemed
- Smith & Nephew
- Sofinnova Partners (France)
- Solid Form Solutions
- SPARK Ventures
- SRA Global Clinical Development
- SR One
- SRCL
- SRG
- State of Georgia UK Office
- Stevenage Bioscience Catalyst
- Stratagem IPM Ltd
- Sudbrook Associates
- Sultan Scientific
- Summit plc
- Syne qua non
- Synergy Outsourcing
- Synergis Technologies
- Syntaxin Ltd
- Syntagon (Sweden)
- Synth-Isis
- Takeda Pharmaceuticals Europe
- Takeda Ventures, Inc. (US)
- Talentmark
- Team Consulting
- Technikos LLP
- Teva
- TFS (Sweden)
- The Communications Strategy Group Inc. (US)
- The Electrospinning Company
- The Pink Sheet (media)
- Theradex Europe
- The Wellcome Trust
- TMRI
- Tissue Solutions Ltd
- Total Scientific Ltd
- TranScrip Partners LLP
- TwistDX Ltd
- Ubichem Pharma Services
- UK BioIncubator Forum
- UKTI
- UMIC
- UMIP
- University of Bradford
- University of Cambridge
- University of Dundee
- University of Edinburgh
- University of Glasgow
- University of Missouri (US)
- University of Oxford
- University of Southampton - Clinical Neurosciences
- University of Southampton - Human Development and Health
- University of Southampton - Infection, Inflammation and Immunity
- Veeda
- Ventech (France)
- Versant EuroVentures (Switzerland)
- Vertex Pharmaceuticals Europe
- VWR International
- Warwick Ventures
- Wellington Partners (Germany)
- Western Provident Association
- WilmerHale
- World Courier
- WPA
- Wragge & Co LLP
- Wuhan National Bioindustry Base (China)
- Xention
- Zealand Pharma (Denmark)